Cargando…
Development of a High-Throughput Screening Assay for Small-Molecule Inhibitors of Androgen Receptor Splice Variants
The role of the androgen receptor (AR) in the progression of prostate cancer (PCa) is well established and competitive inhibition of AR ligand binding domain (LBD) has been the mainstay of antiandrogen therapies for advanced and metastatic disease. However, the efficacy of such drugs is often limite...
Autores principales: | Monaghan, Amy E., Porter, Alison, Hunter, Irene., Morrison, Angus, McElroy, Stuart P., McEwan, Iain J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057896/ https://www.ncbi.nlm.nih.gov/pubmed/35333596 http://dx.doi.org/10.1089/adt.2021.128 |
Ejemplares similares
-
A sting in the tail: the N-terminal domain of the androgen receptor as a drug target
por: Monaghan, Amy E, et al.
Publicado: (2016) -
Identification of Small Molecule Inhibitors of Pre-mRNA Splicing
por: Pawellek, Andrea, et al.
Publicado: (2014) -
Targeting Quorum Sensing: High-Throughput Screening to Identify Novel LsrK Inhibitors
por: Gatta, Viviana, et al.
Publicado: (2019) -
Negative Regulation of the Androgen Receptor Gene Through a Primate-Specific Androgen Response Element Present in the 5′ UTR
por: Hay, Colin W., et al.
Publicado: (2014) -
A high-throughput screen for the identification of compounds that inhibit nematode gene expression by targeting spliced leader trans-splicing
por: Pandarakalam, George Cherian, et al.
Publicado: (2019)